CN1114106A - 苄胺衍生物 - Google Patents

苄胺衍生物 Download PDF

Info

Publication number
CN1114106A
CN1114106A CN94190643A CN94190643A CN1114106A CN 1114106 A CN1114106 A CN 1114106A CN 94190643 A CN94190643 A CN 94190643A CN 94190643 A CN94190643 A CN 94190643A CN 1114106 A CN1114106 A CN 1114106A
Authority
CN
China
Prior art keywords
benzylamine derivative
compound
defined above
salt
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN94190643A
Other languages
English (en)
Chinese (zh)
Inventor
樱井庸二
仓桥伸幸
广瀬毅
三轮贵志
森厚词
西孝夫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of CN1114106A publication Critical patent/CN1114106A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/58Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/04Systems containing only non-condensed rings with a four-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN94190643A 1993-08-30 1994-08-11 苄胺衍生物 Pending CN1114106A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP214147/93 1993-08-30
JP21414793 1993-08-30
JP44003/94 1994-03-15
JP4400394 1994-03-15

Publications (1)

Publication Number Publication Date
CN1114106A true CN1114106A (zh) 1995-12-27

Family

ID=26383844

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94190643A Pending CN1114106A (zh) 1993-08-30 1994-08-11 苄胺衍生物

Country Status (9)

Country Link
US (1) US5550292A (cg-RX-API-DMAC10.html)
EP (1) EP0666840A1 (cg-RX-API-DMAC10.html)
KR (1) KR950704235A (cg-RX-API-DMAC10.html)
CN (1) CN1114106A (cg-RX-API-DMAC10.html)
AU (1) AU667280B2 (cg-RX-API-DMAC10.html)
CA (1) CA2147356A1 (cg-RX-API-DMAC10.html)
PH (1) PH30825A (cg-RX-API-DMAC10.html)
TW (1) TW260661B (cg-RX-API-DMAC10.html)
WO (1) WO1995006630A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840334A (en) * 1997-08-20 1998-11-24 Fuisz Technologies Ltd. Self-binding shearform compositions
US5980941A (en) * 1997-08-20 1999-11-09 Fuisz Technologies Ltd. Self-binding shearform compositions
US5986141A (en) * 1998-09-29 1999-11-16 Eastman Chemical Company Process for the production of cyclopropanemethylamine
EP1634598A1 (en) * 2004-09-07 2006-03-15 Laboratorios Del Dr. Esteve, S.A. Use of piperazine derivatives and analogues for the manufacture of a medicament for the prophylaxis and/or treatment of disorders of food ingestion

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4687865A (en) * 1986-06-04 1987-08-18 E. R. Squibb & Sons, Inc. Process for preparing 7-oxabicycloheptane amino-alcohol intermediates useful in making thromboxane A2 receptor antagonists
CA1327795C (en) * 1987-08-14 1994-03-15 Jules Freedman Antidepressants which are aryloxy inadanamines
IL94466A (en) * 1989-05-25 1995-01-24 Erba Carlo Spa Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
JPH05503517A (ja) * 1989-12-18 1993-06-10 バージニア・コモンウェルス・ユニバーシティ シグマレセプターリガンド及びその用途
WO1993000313A2 (en) * 1991-06-27 1993-01-07 Virginia Commonwealth University Sigma receptor ligands and the use thereof
DE4132013A1 (de) * 1991-09-26 1993-04-01 Basf Ag Neue phenylbenzylamine und diese enthaltende arzneimittel
CA2117250C (en) * 1991-10-04 1999-03-02 Atsuro Nakazato Alkoxyphenylalkylamine derivatives
DE4216941A1 (de) * 1992-05-22 1993-11-25 Basf Ag Para-substituierte Benzylamine und diese enthaltende therapeutische Mittel
DE4327365A1 (de) * 1993-08-14 1995-02-16 Boehringer Mannheim Gmbh Verwendung von Phenolen und Phenolderivaten als Arzneimittel mit fibrinogensenkender Wirkung

Also Published As

Publication number Publication date
AU667280B2 (en) 1996-03-14
PH30825A (en) 1997-10-17
EP0666840A1 (en) 1995-08-16
WO1995006630A1 (en) 1995-03-09
KR950704235A (ko) 1995-11-17
AU7350594A (en) 1995-03-22
CA2147356A1 (en) 1995-03-09
US5550292A (en) 1996-08-27
TW260661B (cg-RX-API-DMAC10.html) 1995-10-21

Similar Documents

Publication Publication Date Title
CN1688544A (zh) 作为蕈毒碱受体拮抗剂的含氟代和磺酰氨基的3,6-二取代的氮杂双环(3.1.0)己烷衍生物
CN1255117A (zh) 兴奋性氨基酸受体调节剂
CN1890208A (zh) 类鸦片受体拮抗剂
CN1859904A (zh) 用于治疗阿尔茨海默氏病的苄醚和苄氨基β-分泌酶抑制剂
CN1168720C (zh) 芳基链烷酰基哒嗪化合物
CN1147248A (zh) N-(3-吡咯烷基)苯甲酰胺衍生物
CN1032438A (zh) 新的取代的n-(1-烷基-3-羟基-4-哌啶基)苯甲酰胺
CN1589256A (zh) 盐酸舍曲林的新多晶型物和含有它们的组合物,制备盐酸舍曲林多晶型物和无定形物的新方法
CN1007727B (zh) 制备四氢化萘衍生物的方法
CN1205704A (zh) 2,7-取代的八氢-吡咯并[1,2-a]吡嗪衍生物
HK1045684B (zh) 联苯基衍生物
CN1216856C (zh) 具有亚环烷基链的新环状化合物,其制备方法和含有它们的药物组合物
CN1114106A (zh) 苄胺衍生物
CN1723204A (zh) 苯并噁唑衍生物及其作为腺苷受体配体的用途
CN1172478A (zh) 喹诺酮衍生物抗血栓形成药
CN1871013A (zh) 作为mao-b抑制剂的苯并氮杂䓬衍生物
CN1345317A (zh) (1-苯甲酰甲基-3-苯基-3-哌啶基乙基)哌啶衍生物,制备它们的方法以及包含它们的药物组合物
CN1023479C (zh) 乙二胺的单酰胺衍生物的制备方法
CN1478074A (zh) 环己基(烷基)-丙醇胺及其制备方法和含有它们的药物组合物
CN101039912A (zh) 吡啶衍生物和它们的制备方法及其治疗应用
CN1023599C (zh) 氯苯胺衍生物的制备方法
CN1062526A (zh) 烷氨基烷基胺和醚化合物及其制造方法和中间产物以及含这些化合物的药剂
CN1147482C (zh) 取代的(二氢)苯并噁嗪和(二氢)苯并噻嗪化合物,其制法和药物组合物
CN88101939A (zh) 对白三烯拮抗剂或有关方面的改进
CN1230173A (zh) 环丁烯-3,4-二酮的取代的n-芳甲基氨基衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication